South Shore Capital Advisors’s Pfizer PFE Stock Holding History

South Shore Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	8,652 +11	+0.1%	+$288	0.14%	151
2026 Q1	$243K	Buy	+8,641	New	+$230K	0.18%	126
2022 Q3	$924K	Sell	21,103 -1,100	-5%	-$53.5K	2.15%	9
2022 Q2	$1.16M	Buy	22,203 +1,260	+6%	+$64.2K	2.43%	7
2022 Q1	$1.08M	Buy	20,943 +2,865	+16%	+$149K	1.77%	9
2021 Q4	$1.07M	Buy	18,078 +2,040	+13%	+$101K	1.74%	10
2021 Q3	$690K	Buy	16,038 +2,735	+21%	+$121K	1.25%	21
2021 Q2	$521K	Buy	13,303 +1,214	+10%	+$47.2K	0.92%	35
2021 Q1	$438K	Buy	+12,089	New	+$429K	0.44%	61

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

South Shore Capital Advisors's PFE Position: Q2 2026 in Review

South Shore Capital Advisors increased its Pfizer (PFE) stake by 0.13% in Q2 2026, buying an estimated $288 and bringing the position to 8,652 shares worth $208K. The position accounts for 0.14% of the portfolio, ranked #151.

South Shore Capital Advisors first reported a position in PFE in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.16M in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

South Shore Capital Advisors held 8,652 shares of Pfizer worth $208K as of Q2 2026.
South Shore Capital Advisors bought 11 Pfizer shares in Q2 2026, an estimated $288.
Pfizer made up 0.14% of South Shore Capital Advisors's portfolio in Q2 2026, its #151 holding.
South Shore Capital Advisors first reported a position in Pfizer in Q1 2021 and has held it in 9 quarters since.
South Shore Capital Advisors's Pfizer position peaked at $1.16M in Q2 2022.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.